(Reuters) – The Trump administration has withdrawn a rule that it had mentioned would decrease drug costs by ending the system of prescription drug after-market reductions referred to as rebates that drugmakers pay to pharmacy profit managers.
FILE PHOTO: Pharmaceutical tablets and capsules are organized within the form of a U.S. greenback signal on a desk on this image illustration taken August 20, 2014. REUTERS/Srdjan Zivulovic/File Picture
Shares of Cigna Corp, the biggest U.S. pharmacy profit supervisor, have been up 13.5 % in early Thursday buying and selling.
The transfer is a setback for the administration, which first launched the thought of eliminating the “protected…